aTYR PHARMA INC Deferred Tax Assets, Operating Loss Carryforwards
aTYR PHARMA INC (ATYR) had Deferred Tax Assets, Operating Loss Carryforwards of $79.10 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-05
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $79.10M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $68.80M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $60.09M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $52.75M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $79.10M 10-K · filed 2026-03-05 |
| 2024-12-31 | $68.80M 10-K · filed 2026-03-05 |
| 2023-12-31 | $60.09M 10-K · filed 2025-03-13 |
| 2022-12-31 | $52.75M 10-K · filed 2024-03-14 |
| 2021-12-31 | $48.83M 10-K · filed 2023-03-14 |
| 2020-12-31 | $41.20M 10-K · filed 2022-03-15 |
| 2019-12-31 | $38.18M 10-K · filed 2021-03-24 |
| 2018-12-31 | $33.00M 10-K · filed 2020-03-26 |
| 2017-12-31 | $27.23M 10-K · filed 2019-03-26 |
| 2016-12-31 | $33.71M 10-K · filed 2018-03-20 |
| 2015-12-31 | $24.87M 10-K · filed 2017-03-16 |
| 2014-12-31 | $20.07M 10-K · filed 2016-03-30 |
| 2013-12-31 | $13.09M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |